Founded in 2012, MindMaze is a global leader in brain technology dedicated to accelerating humanity's ability to recover, learn, and adapt. The company operates at the intersection of neuroscience, biosensing, engineering, mixed reality, and artificial intelligence to enhance recovery potential for patients with neurological diseases.

MindMaze combines FDA cleared and CE marked digital therapeutics with advanced motion analytics, AI, and cloud technologies to create a universal platform for brain health. Beyond healthcare, MindMaze Labs brings cutting-edge neuroscience to everyday life, empowering the next generation of human-machine interfaces.

MindMaze has transformed care for neurological diseases over the past decade with pioneering neurorehabilitation products and technologies. It was the first Swiss unicorn in its sector, achieved multiple FDA and CE certifications, holds numerous patents, and partners with leading research and healthcare institutions globally.

The company continues to innovate in digital therapeutics, teleneurorehabilitation, and smart peripherals, aiming to expand its global commercial footprint and clinical development pipeline for neurological disease treatment.

MindMaze Healthcare focuses on FDA and CE cleared digital therapeutics for neurorehabilitation, while MindMaze Labs concentrates on advanced neuroscience R&D to improve quality of life beyond healthcare.